Drug Profile
Mexiprostil
Alternative Names: DL 646; MDL 646Latest Information Update: 08 Jul 2002
Price :
$50
*
At a glance
- Originator Aventis
- Class Antiulcers; Gastric antisecretories; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peptic ulcer
Most Recent Events
- 22 Dec 1999 Hoechst Marion Roussel has merged with Rhône-Poulenc Rorer to form Aventis Pharma